See more : NC Holdings Co., Ltd. (6236.T) Income Statement Analysis – Financial Results
Complete financial analysis of Kuraray Co., Ltd. (KURRY) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Kuraray Co., Ltd., a leading company in the Chemicals industry within the Basic Materials sector.
You may be interested
- Takamatsu Machinery Co., Ltd. (6155.T) Income Statement Analysis – Financial Results
- TKH Group N.V. (TWEKA.AS) Income Statement Analysis – Financial Results
- Sociedade Comercial Orey Antunes, S.A. (ORE.LS) Income Statement Analysis – Financial Results
- RH (0KTF.L) Income Statement Analysis – Financial Results
- Zug Estates Holding AG (ZUGN.SW) Income Statement Analysis – Financial Results
Kuraray Co., Ltd. (KURRY)
About Kuraray Co., Ltd.
Kuraray Co., Ltd. engages in the production and sale of resins, chemicals, fibers, activated carbon, and high-performance membranes and systems worldwide. The Vinyl Acetate segment manufactures and markets functional resins and films, including PVA, PVB and EVAL. The Isoprene segment engages in the manufacture and marketing of SEPTON thermoplastic elastomer, isoprene-related products, and GENESTAR. The Functional Materials segment manufactures and markets methacrylic resin, medical products, and carbon materials. The Fibers and Textiles segment manufactures and sells synthetic fibers and textiles, CLARINO manmade leather, non-woven fabrics, and other products. The Trading segment mainly processes and sells synthetic fibers and manmade leathers. The company was founded in 1926 and is headquartered in Tokyo, Japan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 780.94B | 756.38B | 629.37B | 541.80B | 575.81B | 603.00B | 518.44B | 485.19B | 411.41B | 521.72B | 369.43B | 368.98B | 363.19B | 332.88B | 376.78B | 417.60B | 385.29B | 375.07B | 354.87B | 332.15B | 322.52B | 305.86B | 313.65B | 316.44B |
| Cost of Revenue | 540.96B | 514.71B | 425.23B | 376.39B | 395.13B | 410.45B | 339.84B | 317.75B | 294.26B | 355.14B | 249.49B | 246.54B | 243.56B | 237.20B | 275.91B | 295.22B | 275.89B | 266.28B | 254.12B | 236.25B | 230.62B | 228.18B | 234.95B | 235.60B |
| Gross Profit | 239.98B | 241.66B | 204.14B | 165.41B | 180.68B | 192.54B | 178.61B | 167.44B | 117.15B | 166.58B | 119.95B | 122.44B | 119.63B | 95.68B | 100.87B | 122.38B | 109.40B | 108.79B | 100.76B | 95.90B | 91.91B | 77.68B | 78.71B | 80.84B |
| Gross Profit Ratio | 30.73% | 31.95% | 32.43% | 30.53% | 31.38% | 31.93% | 34.45% | 34.51% | 28.47% | 31.93% | 32.47% | 33.18% | 32.94% | 28.74% | 26.77% | 29.31% | 28.39% | 29.00% | 28.39% | 28.87% | 28.50% | 25.40% | 25.09% | 25.55% |
| Research & Development | 24.43B | 22.65B | 20.85B | 20.60B | 21.17B | 21.16B | 20.96B | 19.83B | 19.13B | 31.28B | 0.00 | 16.43B | 16.17B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 111.65B | 107.85B | 93.16B | 89.60B | 92.85B | 92.60B | 75.25B | 72.38B | 56.28B | 73.26B | 51.91B | 49.15B | 47.87B | 47.84B | 51.62B | 52.42B | 69.18B | 70.51B | 67.57B | 67.86B | 66.72B | 58.72B | 58.77B | 60.52B |
| Selling & Marketing | 29.79B | 46.68B | 38.72B | 31.46B | 33.66B | 34.15B | 28.24B | 27.24B | 20.57B | 27.25B | 18.84B | 18.55B | 18.66B | 17.39B | 19.96B | 21.83B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 141.44B | 154.52B | 131.88B | 121.07B | 126.51B | 126.75B | 103.49B | 99.62B | 76.85B | 100.51B | 70.75B | 67.70B | 66.53B | 65.23B | 71.58B | 74.25B | 69.18B | 70.51B | 67.57B | 67.86B | 66.72B | 58.72B | 58.77B | 60.52B |
| Other Expenses | -1.37B | -1.43B | -1.99B | -7.14B | -3.49B | -3.50B | -1.27B | -3.05B | -1.90B | -1.06B | -2.14B | -141.00M | -1.29B | -607.00M | -1.67B | -8.47B | -5.80B | -4.79B | -4.24B | -5.02B | -3.86B | -13.18B | -13.41B | -8.06B |
| Operating Expenses | 164.51B | 154.52B | 131.88B | 121.07B | 126.51B | 126.75B | 103.49B | 99.62B | 76.85B | 100.51B | 70.75B | 67.70B | 66.53B | 65.23B | 71.59B | 74.25B | 63.38B | 68.82B | 66.32B | 62.83B | 62.86B | 50.80B | 49.90B | 60.19B |
| Cost & Expenses | 705.46B | 669.24B | 557.11B | 497.45B | 521.63B | 537.20B | 443.32B | 417.36B | 371.11B | 455.64B | 320.23B | 314.24B | 310.10B | 302.43B | 347.50B | 369.47B | 339.26B | 335.10B | 320.44B | 299.07B | 293.48B | 278.98B | 284.85B | 295.79B |
| Interest Income | 1.84B | 450.00M | 141.00M | 208.00M | 346.00M | 388.00M | 266.00M | 223.00M | 220.00M | 239.00M | 449.00M | 415.00M | 375.00M | 407.00M | 463.00M | 714.00M | 1.02B | 1.02B | 741.00M | 1.19B | 1.12B | 1.64B | 2.47B | 3.66B |
| Interest Expense | 2.82B | 1.46B | 1.63B | 1.44B | 1.40B | 1.28B | 729.00M | 739.00M | 251.00M | 724.00M | 966.00M | 1.07B | 1.14B | 1.36B | 1.26B | 835.00M | 419.00M | 414.00M | 297.00M | 656.00M | 1.48B | 2.05B | 2.38B | 2.66B |
| Depreciation & Amortization | 77.16B | 65.46B | 59.00B | 62.46B | 58.16B | 56.70B | 42.97B | 41.56B | 35.70B | 44.10B | 31.40B | 30.74B | 33.54B | 36.49B | 37.15B | 31.49B | 25.50B | 25.19B | 21.32B | 20.79B | 19.11B | 16.06B | 16.59B | 16.77B |
| EBITDA | 141.25B | 152.60B | 131.26B | 106.80B | 112.33B | 122.49B | 118.08B | 109.38B | 110.18B | 100.77B | 81.51B | 80.60B | 85.73B | 80.57B | 65.20B | 57.93B | 71.86B | 61.50B | 59.96B | 51.47B | 44.94B | 34.96B | 49.06B | 41.20B |
| EBITDA Ratio | 18.09% | 20.04% | 20.66% | 18.49% | 18.78% | 19.73% | 22.62% | 22.36% | 18.48% | 20.80% | 22.03% | 23.24% | 23.60% | 20.06% | 17.31% | 3.15% | 18.85% | 16.03% | 16.06% | 15.09% | 14.35% | 12.31% | 15.64% | 13.02% |
| Operating Income | 75.48B | 87.14B | 72.26B | 44.34B | 54.17B | 65.79B | 75.12B | 67.83B | 40.30B | 64.39B | 49.20B | 54.73B | 53.10B | 30.45B | 29.28B | 48.13B | 47.12B | 38.28B | 33.19B | 28.05B | 27.19B | 18.96B | 19.93B | 20.32B |
| Operating Income Ratio | 9.66% | 11.52% | 11.48% | 8.18% | 9.41% | 10.91% | 14.49% | 13.98% | 9.80% | 12.34% | 13.32% | 14.83% | 14.62% | 9.15% | 7.77% | 11.53% | 12.23% | 10.21% | 9.35% | 8.44% | 8.43% | 6.20% | 6.35% | 6.42% |
| Total Other Income/Expenses | -14.20B | -9.14B | -13.56B | -35.21B | -51.28B | -15.75B | -6.98B | -7.32B | 18.22B | -5.88B | -3.95B | -4.30B | -2.37B | 15.44B | -6.20B | -9.76B | -8.59B | -2.70B | -3.91B | -3.34B | -3.70B | -4.59B | -13.73B | -12.52B |
| Income Before Tax | 61.27B | 78.00B | 58.70B | 9.13B | 2.89B | 50.04B | 68.14B | 60.51B | 31.53B | 58.51B | 44.90B | 50.73B | 45.90B | 23.08B | 19.52B | 39.54B | 35.58B | 34.36B | 29.85B | 23.49B | 14.37B | 6.20B | 7.80B | 13.38B |
| Income Before Tax Ratio | 7.85% | 10.31% | 9.33% | 1.68% | 0.50% | 8.30% | 13.14% | 12.47% | 7.66% | 11.22% | 12.15% | 13.75% | 12.64% | 6.93% | 5.18% | 9.47% | 9.24% | 9.16% | 8.41% | 7.07% | 4.46% | 2.03% | 2.49% | 4.23% |
| Income Tax Expense | 18.99B | 22.39B | 20.34B | 5.82B | 3.81B | 15.44B | 13.65B | 19.31B | 9.63B | 22.05B | 15.89B | 18.71B | 17.03B | 6.68B | 6.39B | 13.89B | 13.06B | 13.07B | 11.29B | 8.31B | 6.31B | 3.32B | 3.75B | 5.90B |
| Net Income | 42.45B | 54.31B | 37.26B | 2.57B | -918.00M | 33.56B | 53.60B | 40.40B | 21.30B | 35.75B | 28.80B | 31.47B | 28.74B | 16.32B | 12.98B | 25.55B | 22.41B | 21.19B | 18.47B | 15.18B | 8.05B | 2.87B | 4.05B | 7.45B |
| Net Income Ratio | 5.44% | 7.18% | 5.92% | 0.47% | -0.16% | 5.57% | 10.34% | 8.33% | 5.18% | 6.85% | 7.80% | 8.53% | 7.91% | 4.90% | 3.45% | 6.12% | 5.82% | 5.65% | 5.20% | 4.57% | 2.50% | 0.94% | 1.29% | 2.35% |
| EPS | 126.71 | 161.12 | 108.32 | 7.47 | -2.65 | 287.58 | 457.23 | 344.95 | 182.01 | 305.52 | 247.87 | 271.05 | 247.65 | 140.56 | 111.86 | 216.43 | 182.84 | 172.53 | 150.39 | 122.43 | 63.03 | 22.47 | 31.68 | 60.00 |
| EPS Diluted | 126.71 | 161.00 | 108.23 | 7.47 | -2.65 | 287.58 | 456.02 | 344.25 | 181.52 | 304.71 | 247.56 | 270.63 | 247.32 | 140.43 | 111.78 | 215.97 | 182.40 | 172.23 | 150.36 | 122.43 | 62.13 | 22.35 | 31.38 | 58.26 |
| Weighted Avg Shares Out | 334.99M | 337.05M | 343.99M | 343.88M | 345.82M | 116.70M | 117.23M | 117.12M | 117.01M | 117.01M | 116.18M | 116.10M | 116.06M | 116.07M | 116.08M | 118.07M | 122.58M | 122.80M | 122.78M | 124.00M | 127.73M | 127.55M | 127.68M | 124.20M |
| Weighted Avg Shares Out (Dil) | 334.99M | 337.32M | 344.28M | 344.16M | 345.82M | 116.70M | 117.54M | 117.36M | 117.32M | 117.32M | 116.33M | 116.28M | 116.21M | 116.18M | 116.16M | 118.32M | 122.87M | 123.01M | 122.81M | 124.00M | 129.58M | 128.23M | 128.90M | 127.91M |
Synthetic Leather Market Report 2024 with Forecasts to 2035, Featuring Alfatex, Desserto, H.R. Polycoats, Kuraray, Modern Meadows, MycoWorks, Nirmal Fibers, Teijin Cordley, Wanhua Chemical and More
Dublin, Nov. 12, 2024 (GLOBE NEWSWIRE) -- The "Synthetic Leather Market: Industry Trends and Global Forecasts to 2035: Distribution by Type of Raw Material, Type of Application, Customer Preference, Type of Sector and Geographical Region" report has been added to...
SEKISUI CHEMICAL: Filing of Lawsuit Seeking Injunction and Damages for Patent Infringement in Relation to PVB Interlayer in Germany and Korea
TOKYO--(BUSINESS WIRE)--The High Performance Plastics Company (President: Ikusuke Shimizu) of SEKISUI CHEMICAL CO., LTD. (President and Representative Director: Keita Kato; hereinafter “SEKISUI CHEMICAL”) has filed lawsuits for infringement of its European patent 2 017 237 (“EP '237”), European patent 3...
Global Edible Films and Coatings Industry Research 2025-2035 with Profiles of 35+ Players Including Apeel, DisSolves, FlexSea, FoodBerry, IUV Srl, Kuraray, mori, Notpla, Saveggy, Sun Chemical and Xampla
Dublin, Aug. 27, 2024 (GLOBE NEWSWIRE) -- The "The Global Market for Edible Films and Coatings" report has been added to ResearchAndMarkets.com's offering.
Source: https://incomestatements.info
Category: Stock Reports